2026 NPPES data Ophthalmology Physician NPI 1649634262 M.D.
Verify on CMS →

ABDALA SIRAJELDIN, M.D.

Ophthalmology Physician in ROCHESTER, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 418 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
75%
generic claims · 25% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.4312/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$447.47
13 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ABDALA SIRAJELDIN, M.D. reported a CMS MIPS final score of 91.4312/100 — above the 83.1 national average — and filed 1,123 Medicare Part D claims in 2023.

91.4312/100
MIPS score · +8 vs avg
1K
Part D claims, 2023
75%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ABDALA SIRAJELDIN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ABDALA SIRAJELDIN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ABDALA SIRAJELDIN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 04/09/2016

NPI 1649634262

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

1,123 21% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

91.4312/100 8.33120000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Michigan

How Ophthalmology Physician compares to other specialties among Michigan providers

Michigan providers

Ophthalmology Physician share within Michigan

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Michigan

Medicare quality performance — MIPS

ABDALA SIRAJELDIN, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average

High performer (top quartile)
MIPS Final Score
91.4312/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 91.4312/100 vs national avg 83.1

0%100%National avg83%91.4%
MIPS final score (Ophthalmology Physician) — 91.4312/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ABDALA SIRAJELDIN, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 1101 W UNIVERSITY DR, ROCHESTER, MI, 48307, with a listed phone of (248) 601-4900. NPI 1649634262 was issued on 04/09/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SIRAJELDIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,123 prescription claims written by this provider, covering 418 Medicare beneficiaries and totaling roughly $71K in drug spend, split 25% brand-name and 75% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.4312/100 for the 2023 performance year (Quality 96.389, Cost 75.0484), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1101 W UNIVERSITY DR
ROCHESTER, MI 48307

Provider Details

NPI 1649634262
Specialty Ophthalmology Physician
Credentials M.D.
Gender Male
NPI Issued 04/09/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.4312
Final Score
Avg: 83.1
96.389
Quality
75.0484
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where ABDALA SIRAJELDIN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MEI OPERATIONS, PLLC
FLINT, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ABDALA SIRAJELDIN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$447

Largest payer

Johnson & Johnson Surgical Vision, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to ABDALA SIRAJELDIN, M.D.. To verify ABDALA SIRAJELDIN, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ABDALA SIRAJELDIN, M.D. — brand share 25.0%
Specialty average (est.)

25% brand-name claims vs 75% generic, on 1,123 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,123
Total Claims
$71K
Total Drug Cost
418
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,159
Total Day Supply
60,791
Brand vs Generic
25% brand / 75% generic
Brand Drug Cost
$44K
Generic Drug Cost
$26K
Antibiotic Claims
12

Patient Demographics

Average Patient Age
74.5 years
Avg HCC Risk Score
1.36
Gender Split
55% female / 45% male
Age Distribution
<65: 37, 65-74: 181, 75-84: 140, 85+: 60

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ABDALA SIRAJELDIN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
318
Brimonidine Tartrate
117
Timolol Maleate
107
Erythromycin
Erythromycin Base
99
Prednisolone Acetate
99
Dorzolamide Hcl
81
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
79
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
37
Lumigan
Bimatoprost
23
Rocklatan
Netarsudil Mesylat/Latanoprost
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How ABDALA SIRAJELDIN, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

ABDALA SIRAJELDIN, M.D.'s 1,123 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as SIRAJELDIN.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ABDALA SIRAJELDIN, M.D.'s specialty?
ABDALA SIRAJELDIN, M.D. specializes in Ophthalmology Physician and practices in ROCHESTER, Michigan. Credentials: M.D..
How much does ABDALA SIRAJELDIN, M.D. prescribe under Medicare Part D?
In 2023, ABDALA SIRAJELDIN, M.D. wrote 1,123 Medicare Part D claims totaling $71K in drug costs for 418 beneficiaries.
What is ABDALA SIRAJELDIN, M.D.'s Medicare quality score?
ABDALA SIRAJELDIN, M.D. has a CMS MIPS Final Score of 91.4312/100 (Quality: 96.389, Cost: 75.0484). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ABDALA SIRAJELDIN, M.D. located?
ABDALA SIRAJELDIN, M.D. is located at 1101 W UNIVERSITY DR, ROCHESTER, MI, 48307. Phone: (248) 601-4900.
What is ABDALA SIRAJELDIN, M.D.'s NPI number?
ABDALA SIRAJELDIN, M.D.'s National Provider Identifier (NPI) is 1649634262, issued on 04/09/2016.
Does ABDALA SIRAJELDIN, M.D. prescribe more brand-name or generic drugs?
ABDALA SIRAJELDIN, M.D.'s prescribing is 25% brand-name and 75% generic drugs by claim count, with $44K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does ABDALA SIRAJELDIN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ABDALA SIRAJELDIN, M.D.'s most frequently prescribed drugs include Latanoprost, Brimonidine Tartrate, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ABDALA SIRAJELDIN, M.D. accept Medicare?
ABDALA SIRAJELDIN, M.D. appears in CMS Medicare data with 1,123 Part D claims and 418 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ABDALA SIRAJELDIN, M.D.'s credentials?
ABDALA SIRAJELDIN, M.D.'s NPI is 1649634262 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology